JPS57500195A - - Google Patents

Info

Publication number
JPS57500195A
JPS57500195A JP56501163A JP50116381A JPS57500195A JP S57500195 A JPS57500195 A JP S57500195A JP 56501163 A JP56501163 A JP 56501163A JP 50116381 A JP50116381 A JP 50116381A JP S57500195 A JPS57500195 A JP S57500195A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP56501163A
Other languages
Japanese (ja)
Other versions
JPH036125B2 (cg-RX-API-DMAC7.html
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27383377&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JPS57500195(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US06/126,261 external-priority patent/US4361544A/en
Priority claimed from US06/126,262 external-priority patent/US4348376A/en
Priority claimed from US06/126,263 external-priority patent/US4331647A/en
Application filed filed Critical
Publication of JPS57500195A publication Critical patent/JPS57500195A/ja
Publication of JPH036125B2 publication Critical patent/JPH036125B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3007—Carcino-embryonic Antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A61K51/1048—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell determinant being a carcino embryonic antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Optics & Photonics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Testing Of Coins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Radiation-Therapy Devices (AREA)
  • Nuclear Medicine (AREA)
JP56501163A 1980-03-03 1981-03-02 Expired - Lifetime JPH036125B2 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/126,261 US4361544A (en) 1980-03-03 1980-03-03 Tumor localization and therapy with labeled antibodies specific to intracellular tumor-associated markers
US06/126,262 US4348376A (en) 1980-03-03 1980-03-03 Tumor localization and therapy with labeled anti-CEA antibody
US06/126,263 US4331647A (en) 1980-03-03 1980-03-03 Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers

Related Child Applications (4)

Application Number Title Priority Date Filing Date
JP1135704A Division JPH0684315B2 (ja) 1980-03-03 1989-05-29 ヒト腫瘍治療用注射組成物
JP1135703A Division JPH0720887B2 (ja) 1980-03-03 1989-05-29 ヒト腫瘍治療用注射組成物
JP1135702A Division JPH0684314B2 (ja) 1980-03-03 1989-05-29 ヒト腫瘍造影用注射組成物
JP1135701A Division JPH0684313B2 (ja) 1980-03-03 1989-05-29 ヒト腫瘍造影用注射組成物

Publications (2)

Publication Number Publication Date
JPS57500195A true JPS57500195A (cg-RX-API-DMAC7.html) 1982-02-04
JPH036125B2 JPH036125B2 (cg-RX-API-DMAC7.html) 1991-01-29

Family

ID=27383377

Family Applications (5)

Application Number Title Priority Date Filing Date
JP56501163A Expired - Lifetime JPH036125B2 (cg-RX-API-DMAC7.html) 1980-03-03 1981-03-02
JP1135701A Expired - Lifetime JPH0684313B2 (ja) 1980-03-03 1989-05-29 ヒト腫瘍造影用注射組成物
JP1135703A Expired - Lifetime JPH0720887B2 (ja) 1980-03-03 1989-05-29 ヒト腫瘍治療用注射組成物
JP1135704A Expired - Lifetime JPH0684315B2 (ja) 1980-03-03 1989-05-29 ヒト腫瘍治療用注射組成物
JP1135702A Expired - Lifetime JPH0684314B2 (ja) 1980-03-03 1989-05-29 ヒト腫瘍造影用注射組成物

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP1135701A Expired - Lifetime JPH0684313B2 (ja) 1980-03-03 1989-05-29 ヒト腫瘍造影用注射組成物
JP1135703A Expired - Lifetime JPH0720887B2 (ja) 1980-03-03 1989-05-29 ヒト腫瘍治療用注射組成物
JP1135704A Expired - Lifetime JPH0684315B2 (ja) 1980-03-03 1989-05-29 ヒト腫瘍治療用注射組成物
JP1135702A Expired - Lifetime JPH0684314B2 (ja) 1980-03-03 1989-05-29 ヒト腫瘍造影用注射組成物

Country Status (9)

Country Link
EP (1) EP0035265B1 (cg-RX-API-DMAC7.html)
JP (5) JPH036125B2 (cg-RX-API-DMAC7.html)
AU (2) AU556548B2 (cg-RX-API-DMAC7.html)
CA (1) CA1244344A (cg-RX-API-DMAC7.html)
DE (1) DE3173342D1 (cg-RX-API-DMAC7.html)
DK (1) DK482181A (cg-RX-API-DMAC7.html)
IE (1) IE52040B1 (cg-RX-API-DMAC7.html)
IL (1) IL62267A (cg-RX-API-DMAC7.html)
WO (1) WO1981002522A1 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6242935A (ja) * 1985-07-05 1987-02-24 ミルトン、デ−ビツド、ゴ−ルデンバ−グ 臓器造影剤組成物

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU556548B2 (en) * 1980-03-03 1986-11-06 Milton David Goldenberg Tumor localization and therapy with labeled antibodies and antibody fragments specific to tumor-associated markers
ES8404857A1 (es) * 1981-10-27 1984-05-16 Hybritech Inc Un procedimiento para preparar un anticuerpo monoclonal para un antigeno asociado a un tumor.
DE3382317D1 (de) * 1982-03-15 1991-07-25 Schering Corp Hybride dns, damit hergestellte bindungszusammensetzung und verfahren dafuer.
CA1194415A (en) * 1982-05-05 1985-10-01 E. I. Du Pont De Nemours And Company Immunoglobulin half-molecules and process for producing hybrid antibodies
AU582731B2 (en) * 1983-01-21 1989-04-13 Milton David Goldenberg Specific cea-family antigens, antibodies specific thereto and their methods of use
AU577781B2 (en) * 1983-04-28 1988-10-06 Mark Philip Best Lung imaging with radiolabelled agents
CA1242643A (en) * 1983-08-12 1988-10-04 Eric T. Fossel Nmr imaging utilizing chemical shift reagents
JPS60201260A (ja) * 1984-03-27 1985-10-11 Yamasa Shoyu Co Ltd 心疾患診断薬
US4837003A (en) * 1984-09-13 1989-06-06 Mallinckrodt, Inc. Radiolabeled antibody fragments
US4824659A (en) * 1985-06-07 1989-04-25 Immunomedics, Inc. Antibody conjugates
US5776093A (en) 1985-07-05 1998-07-07 Immunomedics, Inc. Method for imaging and treating organs and tissues
AU6267186A (en) * 1985-09-20 1987-03-26 Regents Of The University Of California, The Dual isotope color functional imaging utilizing radiolabelledmonoclonal antibodies
GB8525974D0 (en) * 1985-10-22 1985-11-27 Nyegaard & Co As Chemical substance
FR2604092B1 (fr) * 1986-09-19 1990-04-13 Immunotech Sa Immunoreactifs destines a cibler les cellules animales pour leur visualisation ou leur destruction in vivo
US5164175A (en) * 1986-12-10 1992-11-17 Hoechst Aktiengesellschaft Diagnostic aid containing an organ-specific substance labeled with technetium-99m
US4867962A (en) * 1988-02-26 1989-09-19 Neorx Corporation Functionally specific antibodies
CA1339415C (en) * 1989-08-24 1997-09-02 Milton David Goldenberg Detection and treatment of infections with immunoconjugates
KR930701201A (ko) * 1990-07-03 1993-06-11 에프.지.엠.헤르만스.에이.지.제이.베르미렌 면역반응성 화합물
GB9115192D0 (en) * 1991-07-12 1991-08-28 Antisoma Ltd Cancer treatment
KR19980038203A (ko) * 1996-11-25 1998-08-05 규오 리 헤 항-간암 마우스 모노클로날 항체에 의해 전달되는 방사성소핵체를 함유하는 의약
US20100215581A1 (en) * 2006-10-25 2010-08-26 Koninklijke Philips Electronics N.V. Contrast agents for detecting prostate cancer

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3927193A (en) * 1973-05-18 1975-12-16 Hoffmann La Roche Localization of tumors by radiolabelled antibodies
US3960827A (en) * 1972-07-10 1976-06-01 Bjoerklund K B Cancer associated polypeptide antigen, process for its preparation, process for preparing antibodies, process of cancer diagnosis and composition useful as an immunizing agent
US4146603A (en) * 1977-02-18 1979-03-27 Research Corporation Tumor specific glycoproteins and method for detecting tumorigenic cancers
US4160019A (en) * 1973-06-25 1979-07-03 Bjorklund Knut B Detection of cancer associated polypeptide antigen and preparation of antibodies thereto
US4160817A (en) * 1976-09-29 1979-07-10 Research Corporation Application of protein-protein interaction as an assay for the detection of cancer
US4174385A (en) * 1976-10-08 1979-11-13 Robert Reid Method of identification of surface proteins of cancer cells, clinical test and method of immunization

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4211766A (en) * 1972-07-10 1980-07-08 Ab Bonnierforetagen Cancer associated polypeptide antigen compositions
DE2643208C2 (de) * 1976-09-25 1985-09-05 Behringwerke Ag, 3550 Marburg Immunologisches Bestimmungsverfahren
US4234561A (en) * 1978-02-06 1980-11-18 Research Corporation Antigen for early pregnancy test and contraceptive vaccine
ZA792457B (en) * 1978-05-22 1981-05-27 Serono Lab Method and composition for cancer detection in humans
AU529951B2 (en) * 1979-10-22 1983-06-30 Samuel Bogoch Detection of malignant tumour cells
AU556548B2 (en) * 1980-03-03 1986-11-06 Milton David Goldenberg Tumor localization and therapy with labeled antibodies and antibody fragments specific to tumor-associated markers

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3960827A (en) * 1972-07-10 1976-06-01 Bjoerklund K B Cancer associated polypeptide antigen, process for its preparation, process for preparing antibodies, process of cancer diagnosis and composition useful as an immunizing agent
US3927193A (en) * 1973-05-18 1975-12-16 Hoffmann La Roche Localization of tumors by radiolabelled antibodies
US4160019A (en) * 1973-06-25 1979-07-03 Bjorklund Knut B Detection of cancer associated polypeptide antigen and preparation of antibodies thereto
US4160817A (en) * 1976-09-29 1979-07-10 Research Corporation Application of protein-protein interaction as an assay for the detection of cancer
US4174385A (en) * 1976-10-08 1979-11-13 Robert Reid Method of identification of surface proteins of cancer cells, clinical test and method of immunization
US4146603A (en) * 1977-02-18 1979-03-27 Research Corporation Tumor specific glycoproteins and method for detecting tumorigenic cancers

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6242935A (ja) * 1985-07-05 1987-02-24 ミルトン、デ−ビツド、ゴ−ルデンバ−グ 臓器造影剤組成物

Also Published As

Publication number Publication date
JPH0684313B2 (ja) 1994-10-26
DE3173342D1 (en) 1986-02-13
JPH0720887B2 (ja) 1995-03-08
CA1244344A (en) 1988-11-08
IE52040B1 (en) 1987-05-27
JPH036125B2 (cg-RX-API-DMAC7.html) 1991-01-29
IE810451L (en) 1981-09-03
JPH03141231A (ja) 1991-06-17
EP0035265B1 (en) 1986-01-02
AU581555B2 (en) 1989-02-23
IL62267A0 (en) 1981-05-20
AU6786887A (en) 1987-04-30
JPH03141230A (ja) 1991-06-17
WO1981002522A1 (en) 1981-09-17
JPH03157338A (ja) 1991-07-05
AU7034181A (en) 1981-09-23
IL62267A (en) 1985-05-31
EP0035265A2 (en) 1981-09-09
AU556548B2 (en) 1986-11-06
JPH0684314B2 (ja) 1994-10-26
EP0035265A3 (en) 1982-04-07
DK482181A (da) 1981-11-02
JPH0684315B2 (ja) 1994-10-26
JPH03157337A (ja) 1991-07-05

Similar Documents

Publication Publication Date Title
FR2473077B1 (cg-RX-API-DMAC7.html)
FR2473414B1 (cg-RX-API-DMAC7.html)
FR2473056B1 (cg-RX-API-DMAC7.html)
FR2473337B1 (cg-RX-API-DMAC7.html)
CH636493A5 (cg-RX-API-DMAC7.html)
FR2473394B1 (cg-RX-API-DMAC7.html)
DE3153250A1 (cg-RX-API-DMAC7.html)
JPS57500195A (cg-RX-API-DMAC7.html)
CH627610B (cg-RX-API-DMAC7.html)
DE3153254A1 (cg-RX-API-DMAC7.html)
FR2481799B1 (cg-RX-API-DMAC7.html)
FR2473352B1 (cg-RX-API-DMAC7.html)
CH657201B (cg-RX-API-DMAC7.html)
DE3115054C2 (cg-RX-API-DMAC7.html)
CH655522B (cg-RX-API-DMAC7.html)
FR2485043B1 (cg-RX-API-DMAC7.html)
IN154902B (cg-RX-API-DMAC7.html)
FR2473265B3 (cg-RX-API-DMAC7.html)
CH655525B (cg-RX-API-DMAC7.html)
FR2457100B1 (cg-RX-API-DMAC7.html)
IN153454B (cg-RX-API-DMAC7.html)
FR2473437B1 (cg-RX-API-DMAC7.html)
FR2473317B1 (cg-RX-API-DMAC7.html)
DE3029945C2 (cg-RX-API-DMAC7.html)
CH636745GA3 (cg-RX-API-DMAC7.html)